| Synonyms: | |
| Status: | Phase 3 |
| Entry Type: | Small molecule |
| Molecule Category: | UNKNOWN |
| UNII: | U604E1NB3K |
| InChI Key | KQDRVXQXKZXMHP-LLVKDONJSA-N |
|---|---|
| Smile | |
| InChI |
|
| Property Name | Value |
|---|---|
| Molecular Formula | C14H21NO3S |
| Molecular Weight | 283.39 |
| AlogP | 2.06 |
| Hydrogen Bond Acceptor | 3.0 |
| Hydrogen Bond Donor | 1.0 |
| Number of Rotational Bond | 5.0 |
| Polar Surface Area | 63.24 |
| Molecular species | ACID |
| Aromatic Rings | 1.0 |
| Heavy Atoms | 19.0 |
| Targets | EC50(nM) | IC50(nM) | Kd(nM) | Ki(nM) | Inhibition(%) | |
|---|---|---|---|---|---|---|
|
Enzyme
Oxidoreductase
|
- | - | - | - | 8 | |
|
Membrane receptor
Family A G protein-coupled receptor
Peptide receptor (family A GPCR)
Chemokine receptor
CXC chemokine receptor
|
- | 1-100 | - | - | 65-68 |
| Mesh Heading | Maximum Phase | Mesh ID | Reference |
|---|---|---|---|
| Diabetes Mellitus, Type 1 | 3 | D003922 | ClinicalTrials |
| Pneumonia, Viral | 3 | D011024 | ClinicalTrials |
| Pancreatitis, Chronic | 2 | D050500 | ClinicalTrials |
| Reperfusion Injury | 2 | D015427 | ClinicalTrials |
| Breast Neoplasms | 2 | D001943 | ClinicalTrials |
| Pneumonia | 2 | D011014 | ClinicalTrials |
| Resources | Reference |
|---|---|
| CAS NUMBER | 266359-83-5 |
| ChEMBL | CHEMBL191413 |
| DrugBank | DB12614 |
| EPA CompTox | DTXSID6046509 |
| FDA SRS | U604E1NB3K |
| Guide to Pharmacology | 8498 |
| PubChem | 9838712 |
| SureChEMBL | SCHEMBL1884299 |
| ZINC | ZINC000000008717 |